FDMT vs LYFT · rev $37.0K vs P/E 108, rev $5.79B
4D Molecular Therapeutics Inc (FDMT) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
FDMT currently screens at market cap $518.1M. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the FDMT and LYFT stock pages for the full models.
Not investment advice.